Australia markets closed

Cytogen, Inc. (217330.KQ)

KOSDAQ - KOSDAQ Delayed price. Currency in KRW
Add to watchlist
8,220.00-500.00 (-5.73%)
At close: 03:30PM KST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
3,268,688
3,184,361
760,777
347,846
413,851
-
Cost of revenue
2,466,547
2,338,140
565,588
290,567
543,479
-
Gross profit
802,141
846,221
195,189
57,278
-129,628
-
Operating expenses
Research development
-
3,117,124
3,197,919
3,315,243
1,738,262
-
Selling general and administrative
5,699,551
2,913,466
2,088,310
1,217,686
900,094
-
Total operating expenses
-
12,637,827
11,692,652
12,918,198
6,457,243
-
Operating income or loss
-8,350,820
-11,791,606
-11,497,463
-12,860,920
-6,586,871
-
Interest expense
-
3,036,506
3,925,399
2,656,420
221,999
-
Income before tax
-15,195,570
-16,179,271
-18,691,658
-13,322,718
-5,009,947
-
Income tax expense
-
-409,770
79,568
-2,452,106
-121,145
-
Income from continuing operations
-14,774,856
-15,769,501
-18,771,226
-10,870,612
-4,888,801
-
Net income
-14,774,856
-15,769,501
-18,771,226
-10,870,612
-4,888,801
-
Net income available to common shareholders
-14,774,856
-15,769,501
-18,771,226
-10,870,612
-4,888,801
-
Basic EPS
-917.00
-
-1.06k
-214.00
-289.33
-245.00
Diluted EPS
-917.00
-
-1.06k
-214.00
-382.00
-245.00
Basic average shares
18,771
-
17,659
50,797
16,897
16,901
Diluted average shares
18,771
-
17,659
50,797
17,300
16,901